New Rapid-acting Antidepressants

Explore the groundbreaking insights in "New Rapid-acting Antidepressants" by Kenji Hashimoto, published by Springer Nature Switzerland AG in 2022. This informative paperback edition, spanning 149 pages, delves into the latest advancements in the field of mental health treatment. Discover innovative candidates for rapid-acting antidepressants, including (R)-ketamine, (2R,6R)-hydroxynorketamine, scopolamine, mGluR2/3 antagonists, and AMPA receptor agonists. Kenji Hashimoto, a leading expert in the field, provides a comprehensive analysis of these emerging therapies, offering hope for those affected by depression. This essential read is perfect for healthcare professionals, researchers, and anyone interested in the future of antidepressant treatments. Don’t miss out on the opportunity to enhance your understanding of rapid-acting antidepressants with this pivotal work.